Lung Cancer: Overview and Practice Questions (2025)

Lung cancer remains a leading cause of cancer-related mortality worldwide and presents a significant concern in the field of respiratory care.

Understanding the pathophysiology, types, staging, and treatment options for lung cancer is crucial for respiratory therapy students. This knowledge not only aids in effective patient care but also contributes to interdisciplinary healthcare efforts aimed at early diagnosis and treatment.

This article aims to provide a comprehensive overview of lung cancer, enriched with practice questions to test your understanding and readiness for real-world applications.

Free Access

RRT Course and Quiz Bundle (Free)

Get free access to 15+ premium courses and quizzes that cover the most essential topics to help you become a Registered Respiratory Therapist (RRT).

Get Free Access

What is Lung Cancer?

Lung cancer is a type of cancer that originates in the lungs, often in cells lining the air passages. It’s primarily caused by smoking, though non-smokers can also develop it.

There are two main types: non-small cell lung cancer and small cell lung cancer. Symptoms may include coughing, chest pain, and shortness of breath. Early detection and treatment are crucial for better outcomes.

Types of Lung Cancer

Lung cancer is broadly categorized into two main types: Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC).

Each of these types has further subtypes, and their characteristics, growth patterns, and treatment options can differ significantly.

Non-Small Cell Lung Cancer (NSCLC)

NSCLC is the most common type of lung cancer, accounting for about 85% of all cases. It tends to grow and spread more slowly than small cell lung cancer.

NSCLC is further divided into several subtypes:

• Adenocarcinoma: This is the most common subtype of NSCLC, particularly among non-smokers. It usually starts in the cells that line the alveoli, the small air sacs in the lungs. Adenocarcinoma tends to be found in the outer regions of the lungs and is often diagnosed before it has spread extensively.
• Squamous Cell Carcinoma: This type of NSCLC begins in the squamous cells, which are flat cells that line the inside of the airways. Squamous cell carcinoma is typically associated with smoking and is more likely to be found in the central part of the lungs, near the main bronchus.
• Large Cell Carcinoma: This is a less common subtype of NSCLC that can appear in any part of the lung. It is named for the large, abnormal-looking cells that are seen under a microscope. Large cell carcinoma tends to grow and spread quickly, making it more challenging to treat.

Small Cell Lung Cancer (SCLC)

SCLC accounts for about 10-15% of all lung cancer cases. It is a highly aggressive form of cancer that grows rapidly and is more likely to spread to other parts of the body early in the course of the disease.

SCLC is strongly associated with smoking and is often found in the central part of the lungs. There are two main subtypes of SCLC:

• Small Cell Carcinoma (Oat Cell Cancer): This is the most common form of SCLC, characterized by small, oval-shaped cells that resemble oats when viewed under a microscope.
• Combined Small Cell Carcinoma: This subtype is a mixture of small cell carcinoma and one or more types of non-small cell lung cancer.

Other Less Common Types of Lung Cancer

In addition to NSCLC and SCLC, there are some rarer forms of lung cancer, including:

• Lung Carcinoid Tumors: These are rare, slow-growing tumors that account for less than 5% of lung cancers. Carcinoid tumors can be divided into typical and atypical carcinoids, with typical carcinoids being less aggressive.
• Mesothelioma: This rare cancer occurs in the lining of the lungs (pleura) and is most often caused by exposure to asbestos.
• Other Tumors: Rare types of lung cancer can include salivary gland tumors, adenoid cystic carcinoma, and other types of sarcomas and lymphomas.

Note: Each type of lung cancer requires a specific approach to treatment, based on its subtype, location, stage, and the overall health of the patient.

Risk Factors

Lung cancer risk factors are conditions, behaviors, or environmental exposures that increase the likelihood of developing the disease.

While smoking is the most well-known risk factor, there are several others to consider:

• Smoking: The leading cause of lung cancer, responsible for about 85-90% of cases. Includes tobacco, cigars, and pipes. Secondhand smoke also poses a significant risk.
• Exposure to Radon Gas: A naturally occurring radioactive gas that can accumulate in homes, particularly in basements. The second leading cause of lung cancer after smoking.
• Asbestos Exposure: Common in certain occupations like construction and shipbuilding. Inhalation of asbestos fibers can lead to lung cancer, particularly mesothelioma.
• Air Pollution: Includes both outdoor air pollution from traffic and industrial emissions, and indoor air pollution from smoke produced by burning wood or coal.
• Previous Lung Diseases: Conditions like chronic obstructive pulmonary disease (COPD) and pulmonary fibrosis increase the risk of developing lung cancer.
• Family History and Genetics: A family history of lung cancer or specific genetic mutations can increase susceptibility, even in non-smokers.
• Age: The risk increases with age, with most cases diagnosed in individuals aged 65 and older.
• Exposure to Radiation: Includes radiation therapy to the chest and occupational exposure in industries like nuclear power plants.
• Exposure to Carcinogens: Certain jobs involve exposure to carcinogens such as arsenic, chromium, nickel, and diesel exhaust, which increase lung cancer risk.
• Diet and Lifestyle Factors: A poor diet low in fruits and vegetables, along with physical inactivity, may contribute to an increased risk of lung cancer.
• Alcohol Consumption: Heavy alcohol use may increase the risk of lung cancer, especially among smokers.
• History of Cancer: A previous diagnosis of certain cancers, particularly if treated with radiation therapy, can increase the risk of lung cancer.

Note: By understanding these risk factors, individuals can take steps to reduce their risk, such as quitting smoking, testing for radon levels at home, and avoiding exposure to known carcinogens.

Symptoms

Lung cancer symptoms can vary depending on the type, location, and stage of the cancer. In the early stages, lung cancer may not cause any symptoms, making it difficult to detect until it has progressed.

However, as the disease advances, several symptoms may become noticeable. Here are the common symptoms of lung cancer:

• Persistent Cough: A cough that doesn’t go away or worsens over time is one of the most common early signs of lung cancer. This cough may be dry or produce mucus.
• Coughing Up Blood (Hemoptysis): Coughing up even a small amount of blood or rust-colored phlegm can be a warning sign of lung cancer and should be evaluated by a healthcare professional.
• Chest Pain: Pain in the chest that worsens with deep breathing, coughing, or laughing may indicate lung cancer. This pain can be caused by the cancer spreading to the lining of the lungs or the ribs.
• Shortness of Breath (Dyspnea): Difficulty breathing or feeling short of breath, even with minimal exertion, is a common symptom as lung cancer obstructs the airways or causes fluid to build up around the lungs.
• Wheezing: A whistling or wheezing sound when breathing can occur if a tumor is blocking the airways. Wheezing can also be a sign of other respiratory conditions like asthma, but it should be checked if persistent.
• Hoarseness: A change in voice, such as becoming hoarse or raspy, can occur if the cancer affects the nerves that control the larynx (voice box).
• Unexplained Weight Loss: Sudden, unexplained weight loss of 10 pounds or more may be a sign of lung cancer or other serious conditions. This is often due to the body using more energy as the cancer grows.
• Loss of Appetite: A reduced desire to eat or a feeling of fullness after eating only a small amount can be related to lung cancer.
• Fatigue: Persistent tiredness or lack of energy that doesn’t improve with rest can be a symptom of lung cancer, especially if it is unexplained by other factors.
• Recurring Respiratory Infections: Frequent episodes of bronchitis, pneumonia, or other respiratory infections can be a sign of lung cancer, as tumors may block airways and cause infections to recur.
• Swelling in the Face or Neck: Swelling of the face, neck, or upper chest can occur if a tumor presses on the superior vena cava, a large vein that carries blood from the upper body to the heart.
• Bone Pain: Lung cancer that has spread to the bones may cause pain in the back, hips, or other areas. This pain is often worse at night and may not improve with rest.
• Headache: Persistent headaches can be a sign that lung cancer has spread to the brain, though this is more common in advanced stages.
• Clubbing of Fingers: Clubbing, or the thickening and rounding of the tips of the fingers or toes, can be a sign of lung cancer, particularly in its more advanced stages. This occurs due to chronic low levels of oxygen in the blood.
• Difficulty Swallowing (Dysphagia): Tumors near the esophagus can cause difficulty swallowing, leading to pain or the sensation that food is stuck in the throat or chest.
• Neurological Symptoms: If lung cancer spreads to the nervous system, it can cause symptoms like weakness, numbness, dizziness, or seizures.
• Horner’s Syndrome: This is a group of symptoms, including drooping of one eyelid, reduced pupil size, and reduced sweating on one side of the face. It can occur if a tumor is located in the upper part of the lungs and affects nearby nerves.
• Paraneoplastic Syndromes: In some cases, lung cancer can cause symptoms unrelated to the lungs or nearby tissues. These may include high calcium levels, blood clots, or hormonal changes that lead to muscle weakness or neurological symptoms.

Note: These symptoms can also be caused by conditions other than lung cancer. However, if you or someone you know is experiencing any of these symptoms, particularly if they are persistent or worsening, it’s crucial to seek medical evaluation for proper diagnosis and treatment. Early detection of lung cancer can significantly improve treatment outcomes.

Diagnosis

Lung cancer diagnosis typically begins with a thorough medical history and physical examination, followed by imaging studies and tissue sampling.

Common diagnostic tools include:

• Imaging Tests: Chest x-rays are often the first test performed if lung cancer is suspected. It can reveal abnormal masses or nodules in the lungs. CT scans provide more detailed images of the lungs and can help determine the size, shape, and location of lung tumors. CT scans are more sensitive than X-rays and can detect smaller lesions. PET scans help identify active cancer cells in the body by showing areas of increased metabolic activity, which is common in cancer cells.
• Sputum Cytology: Examines mucus coughed up from the lungs under a microscope to detect cancer cells.
• Biopsy: A definitive diagnosis is made through a biopsy, where a sample of lung tissue is taken and examined for cancer cells. Biopsies can be done via bronchoscopy, needle biopsy, or surgical methods, depending on the tumor’s location.
• Molecular Testing: These tests may be conducted on biopsy samples to identify specific genetic mutations or markers that can guide targeted therapy.

Note: Early and accurate diagnosis is crucial for determining the appropriate treatment plan and improving outcomes.

Treatment

Lung cancer treatment depends on the type, stage, and overall health of the patient. The main treatment options include:

• Surgery: Typically used for early-stage non-small cell lung cancer (NSCLC), surgery involves removing the tumor and a margin of healthy tissue. Procedures range from lobectomy (removing a lung lobe) to pneumonectomy (removing an entire lung).
• Radiation Therapy: Uses high-energy rays to target and kill cancer cells. It can be used alone or in combination with other treatments, especially for patients who cannot undergo surgery.
• Chemotherapy: Involves the use of drugs to kill rapidly dividing cancer cells. It is often used in advanced stages of both NSCLC and small cell lung cancer (SCLC), either alone or alongside other treatments.
• Targeted Therapy: Focuses on specific genetic mutations in cancer cells, such as EGFR or ALK mutations, using drugs that block these abnormalities and inhibit cancer growth.
• Immunotherapy: Helps the immune system recognize and attack cancer cells. It is often used for advanced lung cancer, particularly when other treatments are ineffective.

Note: Treatment plans are tailored to each patient, aiming to maximize effectiveness while minimizing side effects.

Prognosis

The prognosis for lung cancer depends on factors such as the type, stage at diagnosis, overall health, and response to treatment. Early-stage lung cancer has a better prognosis, with higher survival rates, particularly when treated with surgery.

However, most lung cancers are diagnosed at an advanced stage, where the prognosis is generally poorer. Small cell lung cancer (SCLC) has a more aggressive course and typically has a worse prognosis than non-small cell lung cancer (NSCLC).

Advances in treatments, including targeted therapy and immunotherapy, have improved outcomes for some patients, but overall survival rates remain relatively low.

Prevention

Lung cancer prevention focuses on reducing risk factors and adopting healthy lifestyle practices.

Here are key strategies:

• Avoid Smoking: The most effective way to prevent lung cancer is to never start smoking or to quit if you currently smoke. Smoking is the leading cause of lung cancer, and quitting significantly reduces risk, even for long-term smokers.
• Avoid Secondhand Smoke: Exposure to secondhand smoke can also increase the risk of lung cancer. Avoiding environments where smoking is prevalent and encouraging smoke-free policies can help.
• Test for Radon: Radon is a naturally occurring gas that can accumulate in homes and increase lung cancer risk. Testing your home for radon and taking steps to reduce high levels can be crucial in prevention.
• Protect Against Occupational Hazards: Limit exposure to carcinogens such as asbestos, diesel exhaust, and other industrial chemicals by following safety guidelines and wearing protective equipment.
• Maintain a Healthy Diet: A diet rich in fruits and vegetables may lower the risk of lung cancer. Antioxidants and other nutrients in these foods can help protect against cancer.
• Regular Exercise: Engaging in regular physical activity may reduce the risk of lung cancer and improve overall lung health.
• Reduce Air Pollution Exposure: Minimize exposure to outdoor air pollution and indoor pollutants like smoke from burning fuels, which can increase lung cancer risk.

Note: By adopting these preventive measures, individuals can significantly reduce their risk of developing lung cancer.

Lung Cancer Practice Questions

1. What is lung cancer?
Lung cancer is a major public health problem in the United States (and the world). In the US, approximately 28% of cancer deaths are due to lung cancer. Most of these deaths could be avoided if people did not smoke tobacco-related products.

2. Is smoking cessation important for respiratory therapists?
Yes, smoking cessation helps reduce the number of deaths that occur from lung cancer.

3. What is the leading cause of cancer-related mortality in the United States?
Bronchogenic carcinoma

4. Approximately 85% of all cases of bronchogenic carcinoma are linked to what?
Smoking

5. What are the major histopathologic types of bronchogenic carcinoma?
Adenocarcinoma, squamous cell carcinoma, small cell carcinoma, and large cell carcinoma.

6. What is the most common type of bronchogenic carcinoma?
Adenocarcinoma, which represents more than 40% of all cases.

7. The clinical manifestations of bronchogenic carcinoma result from what?
They result from the local growth of the tumor, regional spread, metastases to extrathoracic and intrathoracic organs, and paraneoplastic syndromes.

8. Lung cancer causes approximately what percentage of all cancer deaths?
It causes approximately 25% of all cancer deaths.

9. What are the most commonly used treatments for patients with non–small cell lung cancer?
Surgical resection, radiation therapy, and chemotherapy

10. The treatment of most patients with small cell carcinoma includes what?
Chemotherapy with radiation therapy

11. What is the most effective way to prevent lung cancer?
Quit smoking

12. What is adenocarcinoma?
A type of cancer characterized by glandular structures

13. What is bronchoalveolar cell carcinoma?
A type of lung cancer characterized by tumor occurrence at the level of the small airways, often masquerading as pneumonia

14. What is large-cell carcinoma?
A type of lung cancer characterized by large cells on microscopy

15. What is a mass?
A body of matter without a definite shape

16. What is a nodule?
A small rounded lump of mineral substance

17. What is non-small cell carcinoma?
This cancer grows more slowly than small-cell lung carcinoma, and it’s not only found in smokers. It occurs in 85-87 percent of lung cancers.

18. What imaging technique is used for the diagnosis of lung cancer?
PET scan

19. Who is squamous cell lung cancer most common in?
It is most common in smokers.

20. What is radiotherapy?
Treatment with radiation

21. What is screening?
Testing objects or persons in order to identify those with particular characteristics.

22. What is small-cell carcinoma?
Malignant, usually bronchogenic epithelial neoplasm consisting of small, tightly packed round, oval, or spindle-shaped epithelial cells that stain darkly and contain neurosecretory granules and little or no cytoplasm.

23. What is squamous cell carcinoma?
A type of lung cancer characterized by cells that appear “plate-like.”

24. What is a staging system?
A method used in cancer registers to identify specific and separate different stages or aspects of the disease.

25. What is TNM staging?
A staging system based on the size of the tumor (T), the presence and position of abnormal lymph nodes (N), and the presence or absence of metastasis (M).

Practice Quiz

Pathology TMC Practice Questions

Access our quiz with sample TMC practice questions and detailed explanations to help you master the key concepts of pathology.

Get Instant Access

26. What is transbronchial needle aspiration?
A technique of sampling lung tissue through a bronchoscope which involves passing a thin needle through a bronchus.

27. What is a transthoracic needle biopsy?
The technique of obtaining a biopsy of lung tissue by which a needle is passed into the chest and often guided by imaging.

28. Why is lung cancer the most common cause of cancer death?
It is found at advanced stages because there are no symptoms in the early stages, there is limited effective therapy for the advanced disease, and the absence of pop-based screening.

29. What is the treatment for lung cancer?
Surgery for early stages, chemo and radiation for regional diseases, and palliative care for advanced stages.

30. What are some other environmental causes of lung cancer besides smoking and radon?
Indoor combustion cook stoves, air pollution, vehicle exhaust, industrial emissions, solid fuel use, asbestos, chromium, and cadmium.

31. Lung cancer staging is based on what?
It is based on the primary tumor size and invasion of surrounding structures, the involvement of draining nodes, and the presence of distant mets.

32. What are the key risk factors for lung cancer?
Cigarette smoke, radon, and asbestos

33. What is necessary for the diagnosis of cancer?
A lung biopsy

34. What are two benign lesions?
(1) Granuloma and (2) Bronchial hamartoma

35. Lung carcinoma can be divided into what?
Two types; small-cell carcinoma and non-small-cell carcinoma

36. Which category of lung cancer is not amiable to surgical resection?
Small cell carcinoma cells are so small the surgeon can’t see them.

37. What are the risk factors for lung cancer?
Smoking; increases with the number of packs smoked per day and the number of years spent smoking; women are at higher risk than males; second-hand smoke; radon; ionizing radiation; occupational exposure; cancer history (lymphomas, head, and neck cancer); genetics; and coexisting lung diseases.

38. Why do women have a higher risk of lung cancer than men?
Differences in nicotine metabolism and hormonal factors.

39. How can the risk of lung cancer be reduced?
It decreases after smoking cessation; measurable difference at 5 years; and an 80-90% reduction after 15 years. For those who smoke more than 15 cigarettes/day, cutting that amount in half reduces the risk by 25%.

40. Who is at high risk for lung cancer?
People aged 55-74 and those with more than 30 pack-year history of smoking are at the greatest risk for lung cancer.

41. What are the screening recommendations for the high-risk population?
Baseline low-dose CT (LDCT) scan; annual LDCT at least x 2 years.

42. What are the routine screening recommendations for high and low-risk groups?
Routine screening is not recommended.

43. What is a unique symptom of lung cancer?
Digital clubbing

44. What are the lab abnormalities of lung cancer?
Hypercalcemia, anemia, leukocytosis, and thrombocytosis.

45. Who is adenocarcinoma most common in?
Non-smokers

46. What tissue sampling is used in the diagnosis of lung cancer?
Tumor biopsy (gold standard), fluid cytology if pleural effusion is present, sputum cytology, mutational status, pulmonary function tests (surgical eligibility), and bone marrow biopsy (neutropenic or thrombocytopenic patient).

47. What are PFTs used for with lung cancer?
They are used to determine surgical eligibility.

48. What is the most aggressive type of lung cancer?
Small cell

49. What is the survival rate without treatment in a patient with small-cell lung cancer?
2-4 months

50. What kind of staging does small cell lung cancer use?
Limited/extensive

51. What are the common symptoms of lung cancer?
Persistent cough, hemoptysis, chest pain, dyspnea, weight loss, and recurrent respiratory infections.

52. What is the most common site for lung cancer metastasis?
The brain, bones, liver, and adrenal glands.

53. What is paraneoplastic syndrome in lung cancer?
A group of symptoms that occur when lung cancer cells produce hormones or other substances affecting distant organs.

54. What is the role of bronchoscopy in lung cancer diagnosis?
Bronchoscopy allows direct visualization and biopsy of lung tumors within the airways.

55. What is the best imaging modality for lung cancer staging?
Positron Emission Tomography (PET) scan.

56. What is the most common paraneoplastic syndrome associated with small-cell lung cancer?
SIADH (Syndrome of Inappropriate Antidiuretic Hormone) leading to hyponatremia.

57. What type of lung cancer is associated with hypercalcemia?
Squamous cell carcinoma.

58. What is the role of chemotherapy in lung cancer treatment?
It is primarily used for small-cell lung cancer and advanced-stage non-small cell lung cancer.

59. What is the most common presenting symptom of lung cancer?
A persistent cough.

60. What are the typical radiographic findings of lung cancer?
A solitary pulmonary nodule, hilar mass, pleural effusion, or atelectasis.

61. What is the most common non-modifiable risk factor for lung cancer?
Genetics and family history.

62. How does second-hand smoke contribute to lung cancer?
It increases the risk of lung cancer by exposing non-smokers to carcinogens.

63. What is the difference between a lung nodule and a lung mass?
A lung nodule is smaller than 3 cm, while a lung mass is larger than 3 cm.

64. What type of biopsy is most commonly used to confirm lung cancer?
A transthoracic needle biopsy.

65. What is the survival rate of lung cancer with early-stage diagnosis?
The five-year survival rate for localized non-small cell lung cancer is approximately 60-70%.

66. How does radon exposure increase the risk of lung cancer?
Radon is a radioactive gas that damages lung cells when inhaled over long periods.

67. What are the most common driver mutations in non-small cell lung cancer?
EGFR mutations, ALK rearrangements, and KRAS mutations.

68. What is the main difference between small cell and non-small cell lung cancer?
Small cell lung cancer grows and spreads more rapidly, while non-small cell lung cancer grows slower and may be treated with surgery.

69. What is the role of immunotherapy in lung cancer treatment?
It helps the immune system recognize and attack cancer cells, primarily in non-small cell lung cancer.

70. What is the prognosis of untreated non-small cell lung cancer?
Without treatment, the survival time for advanced non-small cell lung cancer is typically less than a year.

71. What is the primary method of lung cancer screening?
Low-dose computed tomography (LDCT).

72. What is the hallmark histologic feature of small-cell lung cancer?
Small, round cells with scant cytoplasm and neuroendocrine markers.

73. What is the most common cause of lung cancer in non-smokers?
Exposure to radon gas.

74. How is lung cancer definitively diagnosed?
By histopathologic examination of a biopsy sample.

75. What is the most effective strategy to reduce lung cancer mortality?
Smoking cessation and early detection through screening.

76. What is the purpose of staging in lung cancer?
To determine the extent of disease and guide treatment decisions.

77. What are the early warning signs of lung cancer?
Chronic cough, hoarseness, chest pain, unexplained weight loss, and hemoptysis.

78. What type of lung cancer is most associated with asbestos exposure?
Mesothelioma.

79. What is the significance of a PET scan in lung cancer?
It helps differentiate between benign and malignant lung nodules and assesses metastasis.

80. What are common complications of lung cancer?
Pleural effusion, superior vena cava syndrome, spinal cord compression, and metastasis.

81. What role does surgery play in lung cancer treatment?
It is the primary treatment for early-stage non-small cell lung cancer.

82. What is the best predictor of lung cancer survival?
The stage at the time of diagnosis.

83. Why is lung cancer often diagnosed at an advanced stage?
Because early-stage lung cancer is often asymptomatic.

84. What are common paraneoplastic syndromes associated with lung cancer?
Hypercalcemia, SIADH, Cushing’s syndrome, Lambert-Eaton syndrome.

85. What is the most aggressive type of lung cancer?
Small-cell lung cancer.

86. How is superior vena cava syndrome related to lung cancer?
It occurs when a tumor compresses the superior vena cava, leading to swelling of the face and upper extremities.

87. What is the most common site of metastasis for lung cancer?
The brain.

88. What is the role of palliative care in lung cancer?
To improve the quality of life and manage symptoms in advanced-stage lung cancer.

89. How does lung cancer cause pleural effusion?
Tumor cells invade the pleural space, leading to fluid accumulation.

90. What is the most common radiologic finding in lung cancer?
A solitary pulmonary nodule or mass.

91. What is the primary risk factor for lung cancer?
Cigarette smoking.

92. How does chronic obstructive pulmonary disease (COPD) relate to lung cancer?
COPD is an independent risk factor for lung cancer, and both conditions share common causes like smoking.

93. What is the prognosis for patients with stage IV lung cancer?
Poor prognosis, with a median survival of less than one year without treatment.

94. How does lung cancer cause hoarseness?
By compression or invasion of the recurrent laryngeal nerve.

95. What is the most common presenting symptom of lung cancer?
Persistent cough.

96. How does lung cancer lead to digital clubbing?
Through the release of growth factors that promote changes in the nail bed.

97. What percentage of lung cancer cases occur in never-smokers?
Approximately 10-15%.

98. What is the role of immunotherapy in lung cancer treatment?
It boosts the immune system to recognize and attack cancer cells, often used in advanced non-small cell lung cancer.

99. What is the relationship between secondhand smoke and lung cancer?
Prolonged exposure to secondhand smoke increases the risk of lung cancer.

100. Why is early detection of lung cancer difficult?
Because symptoms often do not appear until the disease is in an advanced stage.

Final Thoughts

Lung cancer remains a significant global health challenge, but advancements in research, diagnosis, and treatment offer hope for better outcomes. Early detection and personalized treatment strategies are vital in improving survival rates and quality of life for those affected by this disease.

By understanding the risk factors and symptoms, individuals can take proactive steps toward prevention and early diagnosis.

Continued research and public awareness are essential in the fight against lung cancer, ultimately leading to more effective treatments and a decrease in mortality rates associated with this devastating illness.